You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our Checkpoint Kinase 2 Proteins (CHEK2)

Full name:
Checkpoint Kinase 2 Proteins (CHEK2)
On www.antibodies-online.com are 10 Checkpoint Kinase 2 (CHEK2) Proteins from 7 different suppliers available. Additionally we are shipping Checkpoint Kinase 2 Antibodies (470) and Checkpoint Kinase 2 Kits (13) and many more products for this protein. A total of 517 Checkpoint Kinase 2 products are currently listed.
Synonyms:
Cds1, CHK-2, Chk2, fa66f08, hCds1, HUCDS1, LFS2, PP1425, Rad53, wu:fa66f08, zgc:55865
list all proteins Gene Name GeneID UniProt
CHEK2 11200 O96017
CHEK2 50883 Q9Z265
Rat CHEK2 CHEK2 114212  

Show all synonyms

Checkpoint Kinase 2 Proteins (CHEK2) by Origin

Select your origin of interest

Top referenced Checkpoint Kinase 2 Proteins

  1. Mouse (Murine) CHEK2 Protein expressed in Baculovirus infected Insect Cells - ABIN2007792 : Matsuoka, Huang, Elledge: Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. in Science (New York, N.Y.) 1998 (PubMed)
    Show all 5 references for ABIN2007792

  2. Human CHEK2 Protein expressed in Wheat germ - ABIN1349305 : Troncale, Barbet, Coulibaly, Henry, He, Barillot, Dubois, Hupé, de Koning: NormaCurve: a SuperCurve-based method that simultaneously quantifies and normalizes reverse phase protein array data. in PLoS ONE 2012 (PubMed)
    Show all 2 references for ABIN1349305

More Proteins for Checkpoint Kinase 2 Interaction Partners

Human Checkpoint Kinase 2 (CHEK2) interaction partners

  1. CHEK2 mutation is associated with Pancreatic Cancer.

  2. Data suggest that nitroxoline induces anticancer activity through AMP (show APRT Proteins)-activated kinase (AMPK (show PRKAA1 Proteins))/mTOR (show FRAP1 Proteins) serine-threonine kinase (show TLK2 Proteins) (mTOR (show FRAP1 Proteins)) signaling pathway via checkpoint kinase 2 (Chk2) activation.

  3. CHEK2 mutation carriers were characterized by older age, a history of gastric cancer in the family, locally advanced disease, lower histologic grade and luminal B type breast cancer.

  4. The germline mutations of the CHEK2 gene are associated with an increased risk of polycythaemia vera (show IGF2BP3 Proteins).

  5. loss of CHK2 or PP6C-SAPS3 promotes Aurora-A activity associated with BRCA1 in mitosis

  6. we observed a great degree of heterogeneity amongst the CHEK2*1100delC breast cancers, comparable to the BRCAX breast cancers. copy number aberrations were mostly seen at low frequencies in both the CHEK2*1100delC and BRCAX group of breast cancers.

  7. The aim of this study was to determine the frequency and spectrum of germline mutations in BRCA1, BRCA2 and PALB2 and to evaluate the presence of the CHEK2 c.1100delC allele in these patients.

  8. germ-line CHEK2 mutations affecting protein coding sequence confer a moderately-increased risk of NHL, they are associated with an unfavorable NHL prognosis, and they may represent a valuable predictive biomarker for patients with DLBCL.

  9. Mutations in CHEK2 were most frequent in patients with hereditary non-triple-negative breast cancers.

  10. Authors propose that CHK2 is a negative regulator of androgen sensitivity and prostate cancer growth, and that CHK2 signaling is lost during prostate cancer progression to castration resistance.

Mouse (Murine) Checkpoint Kinase 2 (CHEK2) interaction partners

  1. We conclude that Chk2 regulates renal 25-hydroxyvitamin D 1alpha-hydroxylase expression thereby impacting on calcium and phosphate metabolism.

  2. TRIP13 (show TRIP13 Proteins)-deficient spermatocytes also progress to an H1t (show HIST1H1T Proteins)-positive stage if ATM (show ATM Proteins) activity is attenuated by hypomorphic mutations in Mre11 (show MRE11A Proteins) or Nbs1 (show NBN Proteins) or by elimination of the ATM (show ATM Proteins)-effector kinase CHK2

  3. Results represent the first demonstration of a role for CHK2 in the in vivo signaling of dysfunctional telomeres.

  4. DNA-PK/Chk2 signaling induces centrosome amplification upon long-term HU treatment, therefore increasing our insight into tumor recurrence after initial chemotherapy.

  5. Results demonstrate that Chk2 plays important roles in regulating cell cycle progression during female meiosis and early embryo development.

  6. These data establish CHK2 as essential for DNA damage surveillance in female meiosis and indicate that the oocyte DNA double-strand breaks damage response primarily involves a pathway hierarchy in which ataxia telangiectasia and Rad3-related (ATR) signals to CHK2, which then activates p53 and p63.

  7. Findings indicate that PIRH2 (show RCHY1 Proteins) has central roles in the ubiquitylation of Chk2 and its turnover and in the regulation of its function.

  8. Chk2 deficiency in Myc (show MYC Proteins) overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP (show PARP1 Proteins) inhibition.

  9. Point mutation at the Nbs1 (show NBN Proteins) Threonine 278 site does not affect mouse development, but compromises the Chk2 and Smc1 (show SMC1A Proteins) phosphorylation after DNA damage.

  10. data indicate that an important role for Chk2 is maintaining lymphocyte development and that dual inactivation of Chk2 and Mus81 (show MUS81 Proteins) remarkably inhibits cancer

Checkpoint Kinase 2 (CHEK2) Protein Profile

Protein Summary

In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with Checkpoint Kinase 2 (CHEK2)

  • serine/threonine-protein kinase chk2 (MCYG_07308)
  • blue sensitive cone opsin (LOC396525)
  • checkpoint kinase 2 (CHEK2)
  • checkpoint kinase 2 (Chek2)
  • CHK2 checkpoint homolog (S. pombe) (chek2)
  • Cds1 protein
  • CHK-2 protein
  • Chk2 protein
  • fa66f08 protein
  • hCds1 protein
  • HUCDS1 protein
  • LFS2 protein
  • PP1425 protein
  • Rad53 protein
  • wu:fa66f08 protein
  • zgc:55865 protein

Protein level used designations for Checkpoint Kinase 2 Proteins (CHEK2)

serine/threonine-protein kinase chk2 , blue cone photoreceptor pigment , blue-sensitive opsin , opsin CHK-2 , CHK2 checkpoint homolog , cds1 homolog , checkpoint-like protein CHK2 , serine/threonine-protein kinase Chk2 , Cds1 homolog , Rad53 homolog , protein kinase Chk2

GENE ID SPECIES
9226831 Arthroderma otae CBS 113480
396525 Gallus gallus
11200 Homo sapiens
50883 Mus musculus
114212 Rattus norvegicus
486338 Canis lupus familiaris
336998 Danio rerio
Selected quality suppliers for Checkpoint Kinase 2 Proteins (CHEK2)
Did you look for something else?